Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


COVID-19: Daily Top 10 Papers


  Liver Diseases

  Free Subscription


26.07.2021

2 Am J Gastroenterol
1 Ann Intern Med
3 BMC Cancer
1 BMC Gastroenterol
1 Clin Res Hepatol Gastroenterol
2 Dig Dis Sci
1 Endoscopy
1 Eur Radiol
7 Gastroenterology
2 Gut
5 Hepatology
1 J Clin Oncol
3 J Gastroenterol Hepatol
1 J Hepatol
1 Nat Rev Cancer
1 Oncogene
2 PLoS One
1 Semin Liver Dis
4 Transplant Proc
6 Transplantation


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    Am J Gastroenterol

  1. MOCTEZUMA-VELAZQUEZ C, Abraldes JG
    Statins and Liver Cancer in Cirrhosis: The Most Relevant Questions Are Still Unanswered.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00051.
    PubMed         Abstract available

  2. LABENZ C, Labenz J
    Proton Pump Inhibitors in Patients With Liver Cirrhosis: Evidence to Improve Their Battered Reputation.
    Am J Gastroenterol. 2021 Jul 19. pii: 00000434-990000000-00048.
    PubMed        


    Ann Intern Med

  3. TAPPER EB, Bosch J
    Annals for Hospitalists Inpatient Notes - Clinical Pearls-Hepatorenal Syndrome.
    Ann Intern Med. 2021;174:HO2-HO3.
    PubMed        


    BMC Cancer

  4. LIU H, Lin L, Lin Z, Chen Y, et al
    Impact of surgical margin width on long-term outcomes for intrahepatic cholangiocarcinoma: a multicenter study.
    BMC Cancer. 2021;21:840.
    PubMed         Abstract available

  5. PERNG DS, Hung CM, Lin HY, Morgan P, et al
    Role of autophagy-related protein in the prognosis of combined hepatocellular carcinoma and cholangiocarcinoma after surgical resection.
    BMC Cancer. 2021;21:828.
    PubMed         Abstract available

  6. SUN J, Dong Z, Chang Z, Liu H, et al
    MARCH6 promotes hepatocellular carcinoma development through up-regulation of ATF2.
    BMC Cancer. 2021;21:827.
    PubMed         Abstract available


    BMC Gastroenterol

  7. HILLERT A, Schultalbers M, Tergast TL, Vonberg RP, et al
    Antimicrobial resistance in patients with decompensated liver cirrhosis and bacterial infections in a tertiary center in Northern Germany.
    BMC Gastroenterol. 2021;21:296.
    PubMed         Abstract available


    Clin Res Hepatol Gastroenterol

  8. LIBERAL R, Gaspar R, Lopes S, Macedo G, et al
    Primary biliary cholangitis in patients with inflammatory bowel disease.
    Clin Res Hepatol Gastroenterol. 2019 Jun 3. pii: S2210-7401(19)30099.
    PubMed         Abstract available


    Dig Dis Sci

  9. CULLARO G, Rubin JB, Fortune BE, Crawford CV, et al
    Association Between Kidney Dysfunction Types and Mortality Among Hospitalized Patients with Cirrhosis.
    Dig Dis Sci. 2021 Jul 22. pii: 10.1007/s10620-021-07159.
    PubMed         Abstract available

  10. HAI Y, Chong W, Eisenbrey JR, Forsberg F, et al
    Network Meta-Analysis: Noninvasive Imaging Modalities for Identifying Clinically Significant Portal Hypertension.
    Dig Dis Sci. 2021 Jul 17. pii: 10.1007/s10620-021-07168.
    PubMed         Abstract available


    Endoscopy

  11. SPAANDER MCW, van der Bogt RD, Baron TH, Albers D, et al
    Esophageal stenting for benign and malignant disease: European Society of Gastrointestinal Endoscopy (ESGE) Guideline - Update 2021.
    Endoscopy. 2021;53:751-762.
    PubMed         Abstract available


    Eur Radiol

  12. ZHOU C, Wang Y, Ma L, Qian X, et al
    Combined hepatocellular carcinoma-cholangiocarcinoma: MRI features correlated with tumor biomarkers and prognosis.
    Eur Radiol. 2021 Jul 19. pii: 10.1007/s00330-021-08188.
    PubMed         Abstract available


    Gastroenterology

  13. YOUNOSSI ZM, Corey KE, Lim JK
    AGA Clinical Practice Update on Lifestyle Modification Using Diet and Exercise to Achieve Weight Loss in the Management of Nonalcoholic Fatty Liver Disease: Expert Review.
    Gastroenterology. 2021;160:912-918.
    PubMed         Abstract available

  14. YE P, Miao H, Chen Y
    An unusual case of symptomatic portal hypertension.
    Gastroenterology. 2021 Jul 16. pii: S0016-5085(21)03253.
    PubMed        

  15. GE J, Pletcher MJ, Lai JC
    Outcomes of SARS-CoV-2 Infection in Patients with Chronic Liver Disease and Cirrhosis: a N3C Study.
    Gastroenterology. 2021 Jul 17. pii: S0016-5085(21)03244.
    PubMed         Abstract available

  16. DE VRIES E, Bolier R, Goet J, Pares A, et al
    Fibrates for itch (FITCH) in fibrosing cholangiopathies: a double blind, randomized, placebo-controlled trial.
    Gastroenterology. 2020 Oct 5. pii: S0016-5085(20)35226.
    PubMed         Abstract available

  17. SHINOZAWA T, Kimura M, Cai Y, Saiki N, et al
    High-Fidelity Drug-Induced Liver Injury Screen Using Human Pluripotent Stem Cell-Derived Organoids.
    Gastroenterology. 2021;160:831-846.
    PubMed         Abstract available

  18. ASEEM SO, Jalan-Sakrikar N, Chi C, Navarro-Corcuera A, et al
    Epigenomic Evaluation of Cholangiocyte TGFbeta Signaling Identifies a Selective Role for Histone 3 Lysine 9 Acetylation in Biliary Fibrosis.
    Gastroenterology. 2020 Oct 12. pii: S0016-5085(20)35245.
    PubMed         Abstract available

  19. VERBOVEN E, Moya IM, Sansores-Garcia L, Xie J, et al
    Regeneration Defects in Yap and Taz Mutant Mouse Livers are Caused by Bile Duct Disruption and Cholestasis.
    Gastroenterology. 2020 Oct 27. pii: S0016-5085(20)35324.
    PubMed         Abstract available


    Gut

  20. BELLINGHAUSEN C, Pletz MW, Rupp J, Witzenrath M, et al
    Chronic liver disease negatively affects outcome in hospitalised patients with community-acquired pneumonia.
    Gut. 2021;70:221-222.
    PubMed        

  21. PETROFF D, Batz O, Jedrysiak K, Kramer J, et al
    Fibrosis-4 (FIB-4) score at the primary care level: an analysis of over 160 000 blood samples.
    Gut. 2021;70:219-221.
    PubMed        


    Hepatology

  22. YANG Q, Chen X, Zhang Y, Hu S, et al
    The E3 ubiquitin ligase RNF5 ameliorates nonalcoholic steatohepatitis via ubiquitin-mediated degradation of HRD1.
    Hepatology. 2021 Jul 17. doi: 10.1002/hep.32061.
    PubMed         Abstract available

  23. HE Q, Liu M, Huang W, Chen X, et al
    IL-1beta-induced Elevation of SLC7A11 Promotes Hepatocellular Carcinoma Metastasis through Upregulating PD-L1 and CSF1.
    Hepatology. 2021 Jul 20. doi: 10.1002/hep.32062.
    PubMed         Abstract available

  24. HU M, Zhang D, Xu H, Zhang Y, et al
    Salidroside activates the AMP-activated protein kinase pathway to suppress non-alcoholic steatohepatitis.
    Hepatology. 2021 Jul 22. doi: 10.1002/hep.32066.
    PubMed         Abstract available

  25. MCMAHON BJ, Nolen S, Snowball M, Homan C, et al
    Hepatitis B Virus (HBV) Genotype: A Significant Risk Factor in Determining which Patients with Chronic HBV Infection should Undergo Surveillance for Hepatocellular Carcinoma: The Hepatitis B Alaska (HEP-B-AK) Study.
    Hepatology. 2021 Jul 22. doi: 10.1002/hep.32065.
    PubMed         Abstract available

  26. LIU G, Wang N, Zhang C, Li M, et al
    ALDOB depletion promotes hepatocellular carcinogenesis through activating insulin receptor signaling and lipogenesis.
    Hepatology. 2021 Jul 22. doi: 10.1002/hep.32064.
    PubMed         Abstract available


    J Clin Oncol

  27. KELLEY RK, Sangro B, Harris W, Ikeda M, et al
    Safety, Efficacy, and Pharmacodynamics of Tremelimumab Plus Durvalumab for Patients With Unresectable Hepatocellular Carcinoma: Randomized Expansion of a Phase I/II Study.
    J Clin Oncol. 2021 Jul 22:JCO2003555. doi: 10.1200/JCO.20.03555.
    PubMed         Abstract available


    J Gastroenterol Hepatol

  28. WU L, Huang XQ, Li N, Xie C, et al
    An MRI Modality for Non-invasively Distinguishing Progression of Liver Fibrosis by Visualizing Hepatic Platelet-Derived Growth Factor Receptor-Beta Expression in Mice.
    J Gastroenterol Hepatol. 2021 Jul 19. doi: 10.1111/jgh.15628.
    PubMed         Abstract available

  29. SHI M, Sheng L, Lian M, Miao Q, et al
    Efficacy and safety of rifampicin in patients with persistent hepatocellular secretory failure.
    J Gastroenterol Hepatol. 2021 Jul 19. doi: 10.1111/jgh.15629.
    PubMed         Abstract available

  30. ATTEBERRY P, Biederman B, Jesudian A, Lucero C, et al
    Mortality, Sepsis, and Organ Failure in Hospitalized Patients with Cirrhosis Vary by Type of Infection.
    J Gastroenterol Hepatol. 2021 Jul 22. doi: 10.1111/jgh.15633.
    PubMed         Abstract available


    J Hepatol

  31. CORNBERG M, Eberhardt CS
    Protected or not protected, that is the question - First data on COVID-19 vaccine responses in patients with NAFLD and liver transplant recipients.
    J Hepatol. 2021 May 25. pii: S0168-8278(21)00342.
    PubMed        


    Nat Rev Cancer

  32. O'LEARY K
    T cell drivers in NASH-HCC.
    Nat Rev Cancer. 2021;21:341.
    PubMed        


    Oncogene

  33. BRAHMA MK, Gilglioni EH, Zhou L, Trepo E, et al
    Oxidative stress in obesity-associated hepatocellular carcinoma: sources, signaling and therapeutic challenges.
    Oncogene. 2021 Jul 21. pii: 10.1038/s41388-021-01950.
    PubMed         Abstract available


    PLoS One

  34. CHEN BW, Chiu GW, He YC, Huang CY, et al
    Extracellular and intracellular intermittent magnetic-fluid hyperthermia treatment of SK-Hep1 hepatocellular carcinoma cells based on magnetic nanoparticles coated with polystyrene sulfonic acid.
    PLoS One. 2021;16:e0245286.
    PubMed         Abstract available

  35. NIRIELLA MA, Ediriweera DS, Kasturiratne A, De Silva ST, et al
    Outcomes of NAFLD and MAFLD: Results from a community-based, prospective cohort study.
    PLoS One. 2021;16:e0245762.
    PubMed         Abstract available


    Semin Liver Dis

  36. KAHL S, Putzer J, Roden M
    Novel Antidiabetic Strategies and Diabetologists' Views in Nonalcoholic Steatohepatitis.
    Semin Liver Dis. 2021 Jul 21. doi: 10.1055/s-0041-1732354.
    PubMed         Abstract available


    Transplant Proc

  37. KURAMITSU K, Yano Y, Komatsu S, Tanaka M, et al
    Indication of Liver Transplantation in the Treatment of Newly Categorized Acute-on-Chronic Liver Failure In Japan.
    Transplant Proc. 2021 May 5. pii: S0041-1345(21)00211.
    PubMed         Abstract available

  38. NOLL AG, Ermentrout RM, Subramanian RM
    Safety and Efficacy of TIPS as a Bridge to Liver Transplantation in Two Cases of Severely High MELD Patients With Variceal Bleeding.
    Transplant Proc. 2021 May 5. pii: S0041-1345(21)00237.
    PubMed         Abstract available

  39. YOSHIYA S, Harada N, Tomiyama T, Takeishi K, et al
    The Significant Prognostic Factors in Prolonged Intensive/High Care Unit Stay After Living Donor Liver Transplantation.
    Transplant Proc. 2021 Apr 30. pii: S0041-1345(21)00212.
    PubMed         Abstract available

  40. AZIZ S, Sey M, Marotta P, Driman D, et al
    Recurrent Hepatocellular Carcinoma After Liver Transplantation: Validation of a Pathologic Risk Score on Explanted Livers to Predict Recurrence.
    Transplant Proc. 2021 Jul 13. pii: S0041-1345(21)00412.
    PubMed         Abstract available


    Transplantation

  41. KOSHY AN, Farouque O, Cailes B, Ko J, et al
    Prediction of Perioperative Cardiovascular Events in Liver Transplantation.
    Transplantation. 2020 May 11. doi: 10.1097/TP.0000000000003306.
    PubMed         Abstract available

  42. KING EA, Brennan DC
    The Science Is Only as Good as the Data: The Case of Fontan-associated Liver Disease.
    Transplantation. 2021;105:23-24.
    PubMed        

  43. AMIN A, Molina A, Quach L, Ito T, et al
    Liver Transplantation in Patients with Pretransplant Aspergillus Colonization: Is It Safe To Proceed?
    Transplantation. 2020 Apr 13. doi: 10.1097/TP.0000000000003276.
    PubMed         Abstract available

  44. SOGBE M, Lopez-Guerra D, Blanco-Fernandez G, Sangro B, et al
    Durvalumab as a Successful Downstaging Therapy for Liver Transplantation in Hepatocellular Carcinoma: the Importance of a Wash-Out Period.
    Transplantation. 2021 Jul 19. pii: 00007890-900000000-95194.
    PubMed        

  45. XUE Y, Liu H, Yang XX, Pang L, et al
    Inhibition of Carnitine Palmitoyltransferase 1A Aggravates Fatty Liver Graft Injury via Promoting Mitochondrial Permeability Transition.
    Transplantation. 2021;105:550-560.
    PubMed         Abstract available

  46. RODRIGUEZ-PERALVAREZ M, Gomez-Bravo MA, Sanchez-Antolin G, De la Rosa G, et al
    Expanding Indications of Liver Transplantation in Spain: Consensus Statement and Recommendations by the Spanish Society of Liver Transplantation.
    Transplantation. 2020 Apr 27. doi: 10.1097/TP.0000000000003281.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Liver Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: